Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-433P is a **pseudogene** of the U6 small nuclear RNA (snRNA) gene family[1][6][7]. Pseudogenes are non-functional sequences that resemble functional genes but typically do not produce functional proteins or RNAs[4][7]. U6 snRNA itself is a crucial component of the spliceosome, the complex responsible for pre-mRNA splicing in eukaryotic cells[3][5]. The human genome contains many pseudogene copies of snRNAs, including U6, formed mainly by retrotransposition events, but these pseudogenes, such as RNU6-433P, generally lack biological activity and do not participate in splicing[7]. There are no roles in disease, drug interactions, or therapeutic targeting known for RNU6-433P. Its identification as a "target" is likely due to confusion with the functional U6 snRNA gene, but RNU6-433P itself is neither a receptor, enzyme, nor any actionable molecular target[6][1][7]. This entry is **correctly identified as a pseudogene**, but is **not a drug target** or relevant receptor/enzyme, and should be excluded in therapeutic drug target databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 433, pseudogene (RNU6-433P).